Eyenovia raises ~$5M via registered direct offering of shares and warrants; amends prior warrants

HYPERION DEFI, INC.

Offering of 7,575,757 shares plus warrants to purchase 7,575,757 shares at $0.66 per unit.
Gross proceeds ~$5M; net to fund Mydcombi/clobetasol commercialization and CHAPERONE study.
Warrants exercisable at $0.69, 6-month lockout, expire Jan 2, 2030.
Prior warrants for ~10.4M shares amended: exercise price cut from ~$2.22 to $0.69, term extended to Jan 1, 2030.
Placement agents: Chardan Capital Markets and Brookline Capital Markets; closing expected July 1, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.